Bangalore, Feb 14
Biocon has tied up with Mylan for development and commercialisation of generic versions of its three insulin analog products. According to Biocon’s Chairman and Managing Director, Kiran...
»
January 25, 2013
Biocon Ltd has announced the following results for the quarter ended December 31, 2012:
The Unaudited results for the Quarter ended December 31, 2012
The Company has posted a net...
»
Pune, Jan 24
The United States Pharmacopeial Convention (USP), a non-profit, standards setting organisation that advances public health through public standards, has named Kiran Mazumdar-Shaw, CMD of Biocon, on...
»
January 8, 2013
Biocon Ltd has informed BSE regarding a Press Release dated January 08, 2013, titled "Biocon Receives Marketing Authorization for its Novel Biologic Itolizumab for Psoriasis".
Source : BSE...
»
New Delhi, Jan 8
Biocon has announced that it has received marketing authorisation from the Drugs Controller General of India (DCGI) for its novel biologic ‘Itolizumab’ – anti-CD6 molecule, for the treatment of ch...
»
December 28, 2012
Biocon Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Source : BSE -
www.bseindia.com<...
»
Bangalore, Nov 26
Biocon has partnered Trinity College Dublin to fund scholarships in genetics research for Indian PhD students.
The company had announced its academic partnership on November 23.
...
»
November 16, 2012
Biocon Ltd has informed BSE regarding a Press Release dated November 16, 2012 titled "Biocon announces that it has entered into an option agreement with Bristol-Myers Squibb for Biocons IN-105, an...
»
March 13, 2013
Biocon Ltd has submitted to BSE details of employee benefit schemes involving dealing in the securities of the Company as per format prescribed in the SEBI circular dated January 17, 2013 on Amendm...
»
Bangalore, Feb. 12
Hopes to achieve sales target of $1 b driven by key biz verticals
»
Bangalore, Jan 25
Overall business growth lifts Biocon’s profit 9.3% in Q3
»
January 25, 2013
Biocon Ltd has informed BSE regarding a Press Release dated January 24, 2013, titled "Kiran Mazumdar-Shaw joins
U.S. Pharmacopeial Convention (USP) Board of Trustees"
Source : BSE -...
»
January 8, 2013
Biocon Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 24, 2013, inter alia, to consider and approve the unaudited financial results of the Comp...
»
Mumbai/Bangalore, Dec. 31
Anil Sardana, Managing Director, Tata Power:
Energy is the indispensable force that drives all economic activity — the higher the country’s energy consumption, the greater the econ...
»
November 29, 2012
Biocon Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Source : BSE -
www.bseindia.com<...
»
Chandigarh, Nov 17
Biotech major Biocon on Saturday said it will soon come out with a new drug for treating inflammatory skin disease Psoriasis as the first clinical trial of the drug has shown encouraging results.<...
»
Bangalore, Nov 16
Biocon has announced that it has entered into an option agreement with Bristol-Myers Squibb Company for Biocon’s IN-105, a prandial oral insulin product candidate. Under the terms of the...
»
